Plasmodium vivax is still susceptible to chloroquine in India [30,31] and anti-folate drugs are not used for treatment of vivax malaria, therefore, the appearance of point mutations in dhfr/dhps is surprising. The gene discussed is DHFR; the disease is Plasmodium vivax malaria.